Přehled o publikaci

he outbreak of monkeypox in multiple non-endemic countries in North America and Europe that started in May 2022 has led to an intensive investigation at both international and national levels for a better understanding of its infection sources and transmission patterns. The classic zoonosis that causes smallpox-like symptoms has experienced substantial epidemiological transformations as inter-human transmission became a predominant pattern through various pathways, including nosocomial infections. TTherefore, healthcare workers with high-risk exposure are among the recommended groups to receive vaccination by the centers of disease control in the European Union (EU) and the United States (US). Dentists need to be aware of and prepared for inter-human transmission risk through aerosolized respiratory droplets and the post-exposure procedures they have to follow, ranging from self-isolation and case reporting to immediate ring vaccination. Considering the low herd-immunity of young generations against orthopoxviruses since the cessation of mass vaccination in the 1980s and the cross-reactivity between the orthopoxviruses that make smallpox vaccines e.g., Jynneos recommended for monkeypox cases; now the emerging question is whether dentists will need to re-add smallpox vaccines to their vaccination schedule in the near future.